Trial
NCT05534984
Study of Tecovirimat for Human Mpox Virus
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
SIGA Technologies
Condition
MPOX
Intervention
Tecovirimat Oral Capsule
Why stopped
DSMB recommendation due to statistical futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-23